Related Experiment Video
Updated: May 10, 2026

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Susceptibility breakpoint for enrofloxacin against swine Salmonella spp
Haihong Hao1, Huafang Pan, Ijaz Ahmad
1National Reference Laboratory of Veterinary Drug Residues/MOA Key Laboratory of the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China.
Abstract:
Susceptibility breakpoints are crucial for prudent use of antimicrobials. This study has developed the first susceptibility breakpoint (MIC ≤ 0.25 μg/ml) for enrofloxacin against swine Salmonella spp. based on wild-type cutoff (COWT) and pharmacokinetic-pharmacodynamic (PK-PD) cutoff (COPD) values, consequently providing a criterion for susceptibility testing and clinical usage of enrofloxacin.
Insights
This study establishes the first enrofloxacin susceptibility breakpoint for swine Salmonella, setting a MIC of ≤ 0.25 μg/ml. This provides a vital criterion for antimicrobial susceptibility testing and clinical use in pigs.
Area of Science:
- Veterinary Microbiology
- Antimicrobial Resistance
- Food Animal Health
Background:
- Prudent antimicrobial use is essential in livestock production.
- Salmonella spp. in swine pose a significant food safety and animal health challenge.
- Enrofloxacin is a critical antimicrobial for treating bacterial infections in food animals.
Purpose of the Study:
- To establish the first susceptibility breakpoint for enrofloxacin against swine Salmonella spp.
- To provide a reliable criterion for enrofloxacin susceptibility testing in veterinary diagnostics.
- To guide the clinical application of enrofloxacin in swine Salmonella infections.
Main Methods:
- Determination of wild-type cutoff (COWT) values.
- Calculation of pharmacokinetic-pharmacodynamic (PK-PD) cutoff (COPD) values.
- MIC determination for enrofloxacin against swine Salmonella isolates.
Main Results:
- The first susceptibility breakpoint for enrofloxacin against swine Salmonella spp. was developed.
- The established breakpoint is a minimum inhibitory concentration (MIC) of ≤ 0.25 μg/ml.
- This breakpoint is based on both COWT and COPD values.
Conclusions:
- A validated susceptibility breakpoint for enrofloxacin in swine Salmonella is now available.
- This breakpoint facilitates accurate susceptibility testing and informed clinical decisions.
- This contributes to responsible antimicrobial stewardship in swine production.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis

